Purification of coagulation factor VIII using chromatographic methods. Direct chromatography of plasma in anion exchange resins

Biotechnology Letters

Volumn 32, Issue 9, 2010, Pages 1207-1214

  Cheng, Elisabeth ^a,b   Jinzenji, Daniela ^a,b   Lorthiois, Ana Paula Almeida Aranha ^a,b   de Carvalho, Roberta Rodrigues ^a   Tanaka Azevedo, Anita Mitiko ^a   Raw, Isaías ^a   Martins, Elizabeth Angélica Leme ^a,b  

^a INSTITUTO BUTANTAN   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anion exchange; Coagulation factors; Factor VIII von Willebrand complexes; Gel filtration; Plasma protein; Purification

Indexed keywords

ANION EXCHANGE; COAGULATION FACTORS; FACTOR VIII/VON WILLEBRAND COMPLEXES; GEL FILTRATION; PLASMA PROTEIN;

CHROMATOGRAPHIC ANALYSIS; CHROMATOGRAPHY; COAGULATION; GEL PERMEATION CHROMATOGRAPHY; IONS; PLASMAS; PROTEINS; PURIFICATION; RESINS;

GELS;

ANION EXCHANGE RESIN; BLOOD CLOTTING FACTOR 8; F8 PROTEIN, HUMAN;

ARTICLE; BIOTECHNOLOGY; CHEMISTRY; GEL CHROMATOGRAPHY; HUMAN; ION EXCHANGE CHROMATOGRAPHY; ISOLATION AND PURIFICATION; METHODOLOGY; PHARMACEUTICS; PLASMA;

ANION EXCHANGE RESINS; BIOTECHNOLOGY; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, ION EXCHANGE; FACTOR VIII; HUMANS; PLASMA; TECHNOLOGY, PHARMACEUTICAL;

EID: 77955717502     PISSN: 01415492     EISSN: 15736776     Source Type: Journal    
DOI: 10.1007/s10529-010-0282-0     Document Type: Article

References (24)

1. Auerswald G, Kreuz W (2008) Haemate P/Humate-P for the treatment of von Willebrand disease: considerations for use and clinical experience. Haemophilia 5(Suppl): 39-46.
2. Burnouf T (2007) Modern plasma fractionation. Transfus Med Rev 21: 101-117.
3. Burnouf T, Burnouf-Radosevich M, Huart JJ, Goudemand M (1991) A highly purified factor VIII: c concentrate prepared from cryoprecipitate by ion-exchange chromatography. Vox Sang 60: 8-15.
4. De Meyer SF, Deckmyn H, Vanhoorelbeke K (2009) von Willebrand factor to the rescue. Blood 113: 5049-5057.
5. Fang H, Wang L, Wang H (2007) The protein structure and effect of factor VIII. Thromb Res 119: 1-13.
6. Federici AB (2008) Prophylaxis of bleeding episodes in patients with von Willebrand's disease. Blood Transfus 2(Suppl): s26-s32.
7. Hoffer L, Schwinn H, Josić D (1999) Production of highly purified clotting factor IX by a combination of different chromatographic methods. J Chromatogr A 844: 119-128.
8. Josic D, Schwinn H, Stadler M, Strancar A (1994) Purification of factor VIII and von Willebrand factor from human plasma by anion exchange chromatography. J Chromatogr B 662: 181-190.
9. Josic D, Hoffer L, Buchacher A (2003) Preparation of vitamin K-dependent proteins, such as clotting factors II, VII, IX and X and clotting inhibitor protein C. J Chromatogr B 790: 183-197.
10. Kaersgaard P, Barington KA (1998) Isolation of the factor VIII-von Willebrand factor complex directly from plasma by gel filtration. J Chromatogr B 715: 357-367.
11. Kaveri S, Gringeri A, Heisel-Kurth M, Kreuz W (2009) Inhibitors in haemophilia A: the role of VWF/FVIII concentrates-a meeting report. Haemophilia 15: 587-591.
12. Kempton CL, White GC II (2009) How we treat a hemophilia A patient with a factor VIII inhibitor. Blood 113: 11-17.
13. Krizek DR, Rick ME (2000) A rapid method to visualize von Willebrand factor multimers by using agarose gel electrophoresis, immunolocalization and luminographic detection. Thromb Res 97: 457-462.
14. Lenting PJ, Christophe OD, Guéguen P (2008) The disappearing act of factor VIII. Haemophilia 1-10. doi: 10. 1111/j. 1365-2516. 2008. 01864. x.
15. Lihme A, Hansen MB, Andersen IV, Burnouf T (2010) A novel core fractionation process of human plasma by expanded bed adsorption chromatography. Anal Biochem 399: 102-109.
16. Miao HZ, Sirachainan N, Palmer L, Kucab P, Cunningham MA, Kaufman RJ, Pipe SW (2004) Bioengineering of coagulation factor VIII for improved secretion. Blood 103: 3412-3419.
17. Mori F, Nardini I, Rossi P, Nardini C, Farina C (2008) Progress in large-scale purification of factor VIII/von Willebrand factor concentrates using ion-exchange chromatography. Vox Sang 95: 298-307.
18. Tanaka AM, Tanaka AS, Lopes APY, Takagi M, Cabrera-Crespo J, Raw I (2000) Purification of porcine plasma factor VIII using chromatographic methods. Biotechnol Lett 22: 257-260.
19. Teh LC, Froger M (1994) Direct capture of plasma factor VIII: C by ion exchange chromatography. Vox Sang 67: 8-13.
20. Terraube V, O'donnell JS, Jenkins, PV (2009) Factor VIII and von Willebrand factor interaction: biological, clinical and therapeutic importance. Haemophilia 1-11. doi: 10. 1111/j. 1365-2516. 2009. 02005. x.
21. Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedures and some applications. Proc Natl Acad Sci USA 76: 4350-4354.
22. Venceslá A, Fuentes-Prior P, Baena M, Quintana M, Baiget M, Tizzano EF (2008) Severe haemophilia A in a female resulting from an inherited gross deletion and a de novo codon deletion in the F8 gene. Haemophilia 14: 1094-1098.
23. Wang W, Wang YJ, Kelner DN (2003) Coagulation factor VIII: structure and stability. Int J Pharm 259: 1-15.
24. Yousef H, Neurath D, Freedman M, Rock G (2006) Cryoprecipitate production: the use of additives to enhance the yield. Clin Lab Haematol 28: 237-240.